DE69128108D1 - Monoklonaler Antikörper gegen HTLV-III (Stamm MN) - Google Patents

Monoklonaler Antikörper gegen HTLV-III (Stamm MN)

Info

Publication number
DE69128108D1
DE69128108D1 DE69128108T DE69128108T DE69128108D1 DE 69128108 D1 DE69128108 D1 DE 69128108D1 DE 69128108 T DE69128108 T DE 69128108T DE 69128108 T DE69128108 T DE 69128108T DE 69128108 D1 DE69128108 D1 DE 69128108D1
Authority
DE
Germany
Prior art keywords
htlv
iiimn
binding
monoclonal antibody
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69128108T
Other languages
English (en)
Other versions
DE69128108T2 (de
Inventor
Yasuyuki Eda
Kiyoshi Osatomi
Kouichi Shiosaki
Sachio Tokiyoshi
Shuzo Matsushita
Toshio Hattori
Kiyoshi Takatsuki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chemo Sero Therapeutic Research Institute Kaketsuken
Original Assignee
Chemo Sero Therapeutic Research Institute Kaketsuken
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chemo Sero Therapeutic Research Institute Kaketsuken filed Critical Chemo Sero Therapeutic Research Institute Kaketsuken
Application granted granted Critical
Publication of DE69128108D1 publication Critical patent/DE69128108D1/de
Publication of DE69128108T2 publication Critical patent/DE69128108T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1036—Retroviridae, e.g. leukemia viruses
    • C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
    • C07K16/1063—Lentiviridae, e.g. HIV, FIV, SIV env, e.g. gp41, gp110/120, gp160, V3, PND, CD4 binding site
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Oncology (AREA)
  • AIDS & HIV (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE69128108T 1990-07-02 1991-07-01 Monoklonaler Antikörper gegen HTLV-III (Stamm MN) Expired - Fee Related DE69128108T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP17507590 1990-07-02
JP2188300A JP2989862B2 (ja) 1990-07-02 1990-07-16 モノクローナル抗体

Publications (2)

Publication Number Publication Date
DE69128108D1 true DE69128108D1 (de) 1997-12-11
DE69128108T2 DE69128108T2 (de) 1998-03-26

Family

ID=26496454

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69128108T Expired - Fee Related DE69128108T2 (de) 1990-07-02 1991-07-01 Monoklonaler Antikörper gegen HTLV-III (Stamm MN)

Country Status (5)

Country Link
EP (1) EP0465979B1 (de)
JP (1) JP2989862B2 (de)
AT (1) ATE159983T1 (de)
AU (1) AU641026B2 (de)
DE (1) DE69128108T2 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2128222C1 (ru) * 1991-08-22 1999-03-27 Ниссин Сокухин Кабусики Кайся Мышиное моноклональное антитело nm01, гибридомная клеточная линия, фрагмент мышиного могоклонального антитела (варианты)
US5558865A (en) * 1991-08-22 1996-09-24 Nissin Shokuhin Kabushiki Kaisha HIV immunotherapeutics
DK0678523T3 (da) * 1993-01-14 2005-01-10 Chemo Sero Therapeut Res Inst Rekombinant anti-HIV antistof og fremstilling deraf
KR100266554B1 (ko) * 1993-01-14 2000-09-15 사꼬 미쓰오 재조합항-hiv항체및그의제조방법
US7048935B2 (en) 1995-04-27 2006-05-23 The United States Of America As Represented By The Department Of Health And Human Services Cyanovirin conjugates and matrix-anchored cyanovirin and related compositions and methods of use
US6987096B1 (en) 1995-04-27 2006-01-17 The United States Of America As Represented By The Department Of Health And Human Services Antiviral proteins and peptides, DNA coding sequences therefor, and uses thereof
US6193982B1 (en) 1995-04-27 2001-02-27 The United States Of America As Represented By The Department Of Health & Human Services Anti-cyanovirin antibody with an internal image of gp120, a method of use thereof, and a method of using a cyanovirin to induce an immune response to gp120
US6780847B2 (en) 1995-04-27 2004-08-24 The United States Of America As Represented By The Department Of Health And Human Services Glycosylation-resistant cyanovirins and related conjugates, compositions, nucleic acids, vectors, host cells, methods of production and methods of using nonglycosylated cyanovirins
US6428790B1 (en) 1995-04-27 2002-08-06 The United States Of America As Represented By The Secretary Department Of Health And Human Services Cyanovirin conjugates and matrix-anchored cyanovirin and related compositions and methods of use
US5843882A (en) 1995-04-27 1998-12-01 The United States Of America As Represented By The Department Of Health And Human Services Antiviral proteins and peptides
JP4307841B2 (ja) 2001-03-22 2009-08-05 アメリカ合衆国 グリコシル化抵抗性シアノビリン及び関連コンジュゲート、組成物、核酸、ベクター、宿主細胞、非グリコシル化シアノビリンの製造方法及び使用方法
CN102066418A (zh) 2007-11-19 2011-05-18 国立大学法人熊本大学 抗hiv单克隆抗体
CN114667281A (zh) 2019-10-29 2022-06-24 国立大学法人熊本大学 具有抗hiv活性的cd4模拟物化合物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3853779T2 (de) * 1987-05-29 1995-09-07 Baylor College Medicine Hiv-1 neutralisierende monoklonale antikörper.
EP0339504A3 (de) * 1988-04-26 1990-09-12 The Du Pont Merck Pharmaceutical Company Menschliches immunoinsuffizientes Virus (HIV) env-codiertes Peptid, welches im Stande ist, die HIV hemmenden Antikörper bei Säugetieren hervorzurufen
EP0436634A1 (de) * 1988-10-03 1991-07-17 Repligen Corporation Hiv-proteine und peptide und deren verwendung zur diagnose, prophylaxe und therapie von aids
WO1990015078A1 (en) * 1989-06-05 1990-12-13 Scott Charles F Jr HUMAN MONOCLONAL ANTIBODIES TO HIV-1MN gp 120

Also Published As

Publication number Publication date
AU641026B2 (en) 1993-09-09
DE69128108T2 (de) 1998-03-26
JP2989862B2 (ja) 1999-12-13
ATE159983T1 (de) 1997-11-15
JPH04152893A (ja) 1992-05-26
EP0465979A1 (de) 1992-01-15
EP0465979B1 (de) 1997-11-05
AU8010791A (en) 1992-01-02

Similar Documents

Publication Publication Date Title
Ljunggren et al. Antibody-dependent cellular cytotoxicity-inducing antibodies against human immunodeficiency virus. Presence at different clinical stages.
Nara et al. Persistent infection of chimpanzees with human immunodeficiency virus: serological responses and properties of reisolated viruses
Nara et al. Purified envelope glycoproteins from human immunodeficiency virus type 1 variants induce individual, type-specific neutralizing antibodies
DE69128108D1 (de) Monoklonaler Antikörper gegen HTLV-III (Stamm MN)
AU632475B2 (en) Human immunodeficiency virus (hiv) env-coded peptide capable of eliciting hiv-inhibiting antibodies in mammals
DE3853779D1 (de) Hiv-1 neutralisierende monoklonale antikörper.
Cavacini et al. Binding and neutralization activity of human IgG1 and IgG3 from serum of HIV-infected individuals
CA2091263A1 (en) Peptides for use in vaccination and induction of neutralizing antibodies against human immunodeficiency virus
DE69332911D1 (de) Rekombinanter humanisierter Antikörper gegen menschlichen Immunschwächevirus
EP0470184A4 (en) Antibodies specific for cd4-binding domain of hiv
DE3855134D1 (de) Monoklonale menschliche antikörper gegen hiv-i
EP1016671A3 (de) Menschliche, monoklonale Antikörper gegen das transmembrane Glycoprotein (gp41) des HIV-1, und verwandte Peptide
CA2192512A1 (en) Nm03 antibody materials and methods
KR930702509A (ko) 사람 면역결핍 바이러스(hiv)면역치료제
Broliden et al. Identification of amino acids in the V3 region of gp120 critical for virus neutralization by human HIV-1-specific antibodies.
AU659839B2 (en) Human immunodeficiency virus-related immune preparation
CA2046016A1 (en) Hiv monoclonal antibody
CA2160696A1 (en) Peptides for use in vaccination and induction of neutralizing antibodies against human immunodeficiency virus
ATE128733T1 (de) Monoklonale antikörper gegen hiv gp120.
Mathiesen et al. Fine analysis of intrathecally synthesized anti-HIV IgG1-4 by peptide mapping
LONDOS-GAGLIARDI et al. Antibodies directed against a variable and neutralizable region of the HTLV-I envelope surface glycoprotein.
ATE137801T1 (de) Gegen hiv 1 gp48 spezifische antikörper
ATE136789T1 (de) Antigene eines transmembranen hüllenglycoproteins eines menschlichen retrovirus des typs hiv-2 und immunologisch verwandte antigene
AU627540B2 (en) Drug for the treatment or prevention by passive immunization, of the hiv-infection and process for preparation thereof
Broliden The specificity and function of HIV antibody response.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee